140 related articles for article (PubMed ID: 26704273)
1. [Demographic change: Changes in society and medicine and developmental trends in geriatrics].
Kolb GF; Weißbach L
Urologe A; 2015 Dec; 54(12):1701-9. PubMed ID: 26704273
[TBL] [Abstract][Full Text] [Related]
2. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
3. Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme.
Gondos A; Krilaviciute A; Smailyte G; Ulys A; Brenner H
Eur J Cancer; 2015 Aug; 51(12):1630-7. PubMed ID: 26044924
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen testing and prostate cancer screening.
Djavan B; Eckersberger E; Finkelstein J; Sadri H; Taneja SS; Lepor H
Prim Care; 2010 Sep; 37(3):441-59, vii. PubMed ID: 20705192
[TBL] [Abstract][Full Text] [Related]
5. In this issue: mini-theme on geriatric care and cancer screening.
Bowman MA; Neale AV
J Am Board Fam Med; 2009; 22(3):231-3. PubMed ID: 19429726
[No Abstract] [Full Text] [Related]
6. Prostate cancer: epidemiology and health-related quality of life.
Penson DF; Rossignol M; Sartor AO; Scardino PT; Abenhaim LL
Urology; 2008 Dec; 72(6 Suppl):S3-11. PubMed ID: 19095126
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
Black A; Berg CD
Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
[TBL] [Abstract][Full Text] [Related]
8. PSA measurement and prostate cancer--overdiagnosis and overtreatment?
Breidablik HJ; Meland E; Aakre KM; Førde OH
Tidsskr Nor Laegeforen; 2013 Sep; 133(16):1711-6. PubMed ID: 24005707
[TBL] [Abstract][Full Text] [Related]
9. Benefits and risks of prostate cancer screening.
Fornara P; Theil G; Schaefer C; Heß J; Rübben H
Oncol Res Treat; 2014; 37 Suppl 3():29-37. PubMed ID: 25195830
[No Abstract] [Full Text] [Related]
10. [Future requirements for oncological care: Challenges due to demographic change].
Wörmann B
Urologe A; 2015 Dec; 54(12):1725-30. PubMed ID: 26704275
[TBL] [Abstract][Full Text] [Related]
11. Screening, risk assessment, and the approach to therapy in patients with prostate cancer.
Freedland SJ
Cancer; 2011 Mar; 117(6):1123-35. PubMed ID: 20960523
[TBL] [Abstract][Full Text] [Related]
12. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
[TBL] [Abstract][Full Text] [Related]
13. [Current results on PSA-based prostate cancer detection].
Graefen M; Schlomm T; Steuber T; Sauter G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Mar; 57(3):312-7. PubMed ID: 24562706
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy.
Roussel B; Ouellet GM; Mohile SG; Dale W
Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120
[TBL] [Abstract][Full Text] [Related]
15. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
16. Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.
Kitagawa Y; Namiki M
Asian J Androl; 2015; 17(3):475-80. PubMed ID: 25578935
[TBL] [Abstract][Full Text] [Related]
17. Cancer overdiagnosis and overtreatment.
Klotz L
Curr Opin Urol; 2012 May; 22(3):203-9. PubMed ID: 22472510
[TBL] [Abstract][Full Text] [Related]
18. Management and geriatric assessment of cancer in the elderly.
Terret C
Expert Rev Anticancer Ther; 2004 Jun; 4(3):469-75. PubMed ID: 15161445
[TBL] [Abstract][Full Text] [Related]
19. Early detection, PSA screening, and management of overdiagnosis.
Borza T; Konijeti R; Kibel AS
Hematol Oncol Clin North Am; 2013 Dec; 27(6):1091-110, vii. PubMed ID: 24188254
[TBL] [Abstract][Full Text] [Related]
20. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]